FDA weighs whether Lasik patients should be given extra warning about possible risks
(NEW YORK) -- The Food and Drug Administration is weighing whether or not surgeons should provide additional warnings about the risks of Lasik, a popular corrective eye-sight surgery.
In a draft guidance from July, the agency suggested that patients should be explicitly informed about the... Read More.
